[{"address1": "680 East Colorado Boulevard", "address2": "Suite 180", "city": "Pasadena", "state": "CA", "zip": "91101", "country": "United States", "phone": "631 830 7092", "fax": "631 982 5050", "website": "https://lixte.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bastiaan  van der Baan M.Sc.", "age": 52, "title": "Chief Scientific Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 172784, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Geordan G. Pursglove", "age": 36, "title": "CEO, President & Chairman", "yearBorn": 1988, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter M. Stazzone", "age": 71, "title": "Chief Financial Officer", "yearBorn": 1953, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.168, "open": 0.1675, "dayLow": 0.1675, "dayHigh": 0.1836, "regularMarketPreviousClose": 0.168, "regularMarketOpen": 0.1675, "regularMarketDayLow": 0.1675, "regularMarketDayHigh": 0.1836, "beta": 0.495, "volume": 1497, "regularMarketVolume": 1497, "averageVolume": 17681, "averageVolume10days": 13610, "averageDailyVolume10Day": 13610, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fiftyTwoWeekLow": 0.02, "fiftyTwoWeekHigh": 0.38, "allTimeHigh": 6.77, "allTimeLow": 0.019, "fiftyDayAverage": 0.2006, "twoHundredDayAverage": 0.0884, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "profitMargins": 0.0, "floatShares": 4267657, "bookValue": 0.236, "priceToBook": 0.77372885, "netIncomeToCommon": -3088952, "52WeekChange": 2.5192308, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 0.1826, "recommendationKey": "none", "totalCash": 887212, "totalCashPerShare": 0.195, "totalDebt": 0, "quickRatio": 1.652, "currentRatio": 1.843, "returnOnAssets": -0.99791, "returnOnEquity": -2.1320798, "freeCashflow": -1292541, "operatingCashflow": -2612238, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "LIXTW", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1759521600, "marketState": "CLOSED", "regularMarketChangePercent": 8.690481, "regularMarketPrice": 0.1826, "exchange": "NCM", "messageBoardId": "finmb_29181356", "exchangeTimezoneName": "America/New_York", "fiftyDayAverageChange": -0.017999992, "fiftyDayAverageChangePercent": -0.08973077, "twoHundredDayAverageChange": 0.09420001, "twoHundredDayAverageChangePercent": 1.065611, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "fullExchangeName": "NasdaqCM", "shortName": "Lixte Biotechnology Holdings, I", "longName": "Lixte Biotechnology Holdings, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1606487400000, "regularMarketChange": 0.014600009, "regularMarketDayRange": "0.1675 - 0.1836", "averageDailyVolume3Month": 17681, "fiftyTwoWeekLowChange": 0.16260001, "fiftyTwoWeekLowChangePercent": 8.130001, "fiftyTwoWeekRange": "0.02 - 0.38", "fiftyTwoWeekHighChange": -0.19739999, "fiftyTwoWeekHighChangePercent": -0.5194737, "fiftyTwoWeekChangePercent": 251.92308, "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Lixte Biotechnology", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]